Company news
Artelo Biosciences, Inc. news in 2023
Artelo Biosciences, Inc.'s news releases, calls and decks from 2023, newest first.
Artelo Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update
November 12, 2023
Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating Protective Properties of ART27.13 Against Muscle Degeneration Caused by Certain Cancers
November 8, 2023
Artelo Biosciences Completes Positive Pre-IND Meeting with FDA for ART26.12
September 6, 2023
Artelo Biosciences Reports Second Quarter 2023 Financial Results and Provides Business Update
August 9, 2023
Artelo Biosciences Announces Sponsorship of The William A. Devane Early Career Investigator Award at the 33rd Annual International Cannabinoid Research Society Symposium
June 27, 2023
Artelo Biosciences Announces Important New Data on ART26.12 Demonstrating Positive Effects in Multiple Models of Neuropathic Pain at the 33rd Annual International Cannabinoid Research Society Symposium
June 26, 2023
Artelo Biosciences Selected for Oral Presentation to Report Positive Research Findings on ART12.11 at the 33rd Annual International Cannabinoid Research Society Symposium
June 6, 2023
Artelo Biosciences Reports First Quarter 2023 Financial Results and Provides Business Update
May 10, 2023
Artelo Biosciences Initiates the Phase 2a Portion of its CAReS Trial EvaluatingART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss
April 24, 2023
Artelo Biosciences Reports Fiscal 2022 Year-End Financial Results and Provides Business Update
March 30, 2023
Artelo Biosciences Completes Enrollment of the Phase 1b Stage of its CAReS Clinical Trial Evaluating ART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss
February 1, 2023